Amyris: The Losing Streak Continues (AMRS)

Published on Tue, 05/15/2012 - 13:58
By Adrienne Chilton in 52 Week high-lows, amrs, 52 week high/lows, amyris, nasdaq:amrs

Amyris (NASDAQ:AMRS) traded today at a new 52-week low of $1.79. Approximately 374,000 shares have changed hands today, as compared to an average 30-day volume of 457,000 shares.

Amyris, Inc. is a renewable products company. The Company provides alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Amyris is developing Brazilian sugarcane as its primary feedstock.

There is potential upside of 65.7% for shares of Amyris based on a current price of $1.81 and an average consensus analyst price target of $3.00. The stock should find initial resistance at its 50-day moving average (MA) of $4.03 and further resistance at its 200-day MA of $11.71.

Over the past year, Amyrishas traded in a range of $1.79 to $30.78 and are now at $1.81. The 200-day and 50-day moving averages have moved 2.72% lower and 4.51% lower over the past week, respectively.

By Adrienne Chilton
achilton@fnno.com
video platform video management video solutions video player {SEO}

Latest News from FNNO

Analyst Rating In Review: Ducommun Sold ...

One week ago Ducommun (NYSE:DCO) was downgraded from Buy to Hold at BB&T Capital. The ...

Analyst Rating Flashback: Analog Devices...

Analog Devices was downgraded from Buy to Neutral by UBS one week ago. The shares clos ...

Janney Montgomery Made the Right Call, C...

Chiquita Brands International was downgraded from Buy to Neutral by Janney Montgomery o ...

CF Industries Gives Way to the Analysts:...

One week ago CF Industries (NYSE:CF) was downgraded from Hold to Sell at Dahlman Rose. ...

Parkway Properties Down 2.9% Since BMO C...

A week ago, BMO Capital upgraded Parkway Properties from Underperform to Market Perform ...

Analyst Rating In Review: Marvell Techno...

One week ago Marvell Technology (NASDAQ:MRVL) was downgraded from Buy to Neutral at UBS ...

Analyst Rating In Review: MercadoLibre S...

A week ago, Raymond James downgraded MercadoLibre from Outperform to Market Perform. T ...

Analyst Rating Flashback: Humana Down 3....

A week ago, Goldman Sachs downgraded Humana from Buy to Neutral. Humana stocks closed ...